Unlocking the full potential of inhalation technologies and therapies

Senzer develop, manufacture and licences pioneering respiratory products for the delivery of pharmaceutical cannabinoids

Breaking news

Senzer’s Pharmaceutical Inhaler selected for Major Cannabinoid Patient Registry

Read More

Unique respiratory cannabinoid delivery

Senzer is a pharmaceutical company which develops, manufactures and licences innovative respiratory devices intended for the safe and reliable delivery of pharmaceutical cannabinoids.

Cannabinoids have long been identified as promising treatment options for a range of conditions, including those associated with cancer treatment; however, the drawbacks of oral delivery have limited their uptake. Senzer’s innovative inhalation platform is able to deliver cannabinoids with a fast uptake as compared to oral formulation, allowing for the development of new treatment options that can be easily self-administered. Our products aspire to make a real and tangible difference to a patient’s quality of life by advancing the treatment options available.

At Senzer, we’re discovering new ways to make life better. From research and development through to commercialisation, we explore, innovate and modify our technologies to complement and enhance existing conventional and alternative treatments to ensure we are a leader in this field.

Recent News

Jan 6 2020
Senzer Limited - Logo
Senzer Limited - Logo
Senzer Limited
Press release

Senzer’s Pharmaceutical Inhaler selected for Major Cannabinoid Patient Registry

Senzer’s pharmaceutical respiratory device will be used in Europe’s first and biggest national medical cannabis registry, Project TWENTY21, in which an expected 20,000 patients will be enrolled by the end of 2021 creating the largest body of evidence for the efficacy of medical cannabis. Drug Science, the leading independent scientific body on drugs in the...

Read More
Jan 6 2020
Senzer Limited - Logo
Senzer Limited - Logo
Senzer Limited
Press release

Senzer’s Respiratory Cannabinoid Device Notches Up Another Design Award

Senzer's pharmaceutical cannabinoid device has won another major design award, with the German Design Council commending the unique inhaler for having 'a clear modern design that perfectly combines ergonomics and functionality'.    The award is the third design success for Senzer's Class IIa Medical Device, which is breath-activated and delivers a precise dose of pharmaceutical cannabinoids, and has been used...

Read More
Sep 17 2019
Senzer Limited - Logo
Senzer Limited - Logo
Senzer Limited
Press release

Senzer’s Medical Device Approved in Europe for the Safe and Effective Delivery of Cannabinoids

Senzer Pharmaceuticals has been granted a CE Mark that certifies its inhaler as a medical device, allowing it to now be available for patients in Europe for the 'safe and effective delivery of pharmaceutical cannabinoids.' The Class IIa Medical Device approval is the first-ever in the cannabinoid space and clears the way for the UK-based Company to supply...

Read More